These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
406 related articles for article (PubMed ID: 23434349)
21. Novel self-assembling PEG-p-(CL-co-TMC) polymeric micelles as safe and effective delivery system for paclitaxel. Danhier F; Magotteaux N; Ucakar B; Lecouturier N; Brewster M; Préat V Eur J Pharm Biopharm; 2009 Oct; 73(2):230-8. PubMed ID: 19577643 [TBL] [Abstract][Full Text] [Related]
22. In vivo comparative study of distinct polymeric architectures bearing a combination of paclitaxel and doxorubicin at a synergistic ratio. Baabur-Cohen H; Vossen LI; Krüger HR; Eldar-Boock A; Yeini E; Landa-Rouben N; Tiram G; Wedepohl S; Markovsky E; Leor J; Calderón M; Satchi-Fainaro R J Control Release; 2017 Jul; 257():118-131. PubMed ID: 27374630 [TBL] [Abstract][Full Text] [Related]
23. Selective tissue distribution and long circulation endowed by paclitaxel loaded PEGylated poly(ε-caprolactone-co-L-lactide) micelles leading to improved anti-tumor effects and low systematic toxicity. Wang F; Shen Y; Xu X; Lv L; Li Y; Liu J; Li M; Guo A; Guo S; Jin F Int J Pharm; 2013 Nov; 456(1):101-12. PubMed ID: 23968782 [TBL] [Abstract][Full Text] [Related]
24. The eradication of breast cancer and cancer stem cells using octreotide modified paclitaxel active targeting micelles and salinomycin passive targeting micelles. Zhang Y; Zhang H; Wang X; Wang J; Zhang X; Zhang Q Biomaterials; 2012 Jan; 33(2):679-91. PubMed ID: 22019123 [TBL] [Abstract][Full Text] [Related]
25. Well-Defined Redox-Sensitive Polyethene Glycol-Paclitaxel Prodrug Conjugate for Tumor-Specific Delivery of Paclitaxel Using Octreotide for Tumor Targeting. Yin T; Wu Q; Wang L; Yin L; Zhou J; Huo M Mol Pharm; 2015 Aug; 12(8):3020-31. PubMed ID: 26086430 [TBL] [Abstract][Full Text] [Related]
26. Free paclitaxel-loaded E-selectin binding peptide modified micelle self-assembled from hyaluronic acid-paclitaxel conjugate inhibit breast cancer metastasis in a murine model. Han X; Dong X; Li J; Wang M; Luo L; Li Z; Lu X; He R; Xu R; Gong M Int J Pharm; 2017 Aug; 528(1-2):33-46. PubMed ID: 28576551 [TBL] [Abstract][Full Text] [Related]
28. A novel combined micellar system of lapatinib and Paclitaxel with enhanced antineoplastic effect against human epidermal growth factor receptor-2 positive breast tumor in vitro. Wei Y; Xu S; Wang F; Zou A; Zhang S; Xiong Y; Cao S; Zhang Q; Wang Y; Jiang X J Pharm Sci; 2015 Jan; 104(1):165-77. PubMed ID: 25421492 [TBL] [Abstract][Full Text] [Related]
29. Galactose-decorated cross-linked biodegradable poly(ethylene glycol)-b-poly(ε-caprolactone) block copolymer micelles for enhanced hepatoma-targeting delivery of paclitaxel. Yang R; Meng F; Ma S; Huang F; Liu H; Zhong Z Biomacromolecules; 2011 Aug; 12(8):3047-55. PubMed ID: 21726090 [TBL] [Abstract][Full Text] [Related]
30. Complete Regression of Xenograft Tumors upon Targeted Delivery of Paclitaxel via Π-Π Stacking Stabilized Polymeric Micelles. Shi Y; van der Meel R; Theek B; Oude Blenke E; Pieters EH; Fens MH; Ehling J; Schiffelers RM; Storm G; van Nostrum CF; Lammers T; Hennink WE ACS Nano; 2015; 9(4):3740-52. PubMed ID: 25831471 [TBL] [Abstract][Full Text] [Related]
31. Herceptin-conjugated paclitaxel loaded PCL-PEG worm-like nanocrystal micelles for the combinatorial treatment of HER2-positive breast cancer. Peng J; Chen J; Xie F; Bao W; Xu H; Wang H; Xu Y; Du Z Biomaterials; 2019 Nov; 222():119420. PubMed ID: 31445322 [TBL] [Abstract][Full Text] [Related]
32. Hyaluronic acid-shelled acid-activatable paclitaxel prodrug micelles effectively target and treat CD44-overexpressing human breast tumor xenografts in vivo. Zhong Y; Goltsche K; Cheng L; Xie F; Meng F; Deng C; Zhong Z; Haag R Biomaterials; 2016 Apr; 84():250-261. PubMed ID: 26851390 [TBL] [Abstract][Full Text] [Related]
33. Paclitaxel-Loaded Mixed Micelles Enhance Ovarian Cancer Therapy through Extracellular pH-Triggered PEG Detachment and Endosomal Escape. Zhao H; Li Q; Hong Z Mol Pharm; 2016 Jul; 13(7):2411-22. PubMed ID: 27266442 [TBL] [Abstract][Full Text] [Related]
34. Novel Soluplus(®)-TPGS mixed micelles for encapsulation of paclitaxel with enhanced in vitro cytotoxicity on breast and ovarian cancer cell lines. Bernabeu E; Gonzalez L; Cagel M; Gergic EP; Moretton MA; Chiappetta DA Colloids Surf B Biointerfaces; 2016 Apr; 140():403-411. PubMed ID: 26780253 [TBL] [Abstract][Full Text] [Related]
35. Poly(ethylene glycol)-block-poly(ε-caprolactone)-and phospholipid-based stealth nanoparticles with enhanced therapeutic efficacy on murine breast cancer by improved intracellular drug delivery. He X; Li L; Su H; Zhou D; Song H; Wang L; Jiang X Int J Nanomedicine; 2015; 10():1791-804. PubMed ID: 25784805 [TBL] [Abstract][Full Text] [Related]
36. Calcium phosphate nanoparticles functionalized with alendronate-conjugated polyethylene glycol (PEG) for the treatment of bone metastasis. Chu W; Huang Y; Yang C; Liao Y; Zhang X; Yan M; Cui S; Zhao C Int J Pharm; 2017 Jan; 516(1-2):352-363. PubMed ID: 27887884 [TBL] [Abstract][Full Text] [Related]
37. Polypeptide-based combination of paclitaxel and cisplatin for enhanced chemotherapy efficacy and reduced side-effects. Song W; Tang Z; Li M; Lv S; Sun H; Deng M; Liu H; Chen X Acta Biomater; 2014 Mar; 10(3):1392-402. PubMed ID: 24316362 [TBL] [Abstract][Full Text] [Related]
38. Alendronate-functionalized porous nano-crystalsomes mitigate osteolysis and consequent inhibition of tumor growth in a tibia-induced metastasis model. Shukla RP; Tiwari P; Sardar A; Urandur S; Gautam S; Marwaha D; Tripathi AK; Rai N; Trivedi R; Mishra PR J Control Release; 2024 Aug; 372():331-346. PubMed ID: 38844176 [TBL] [Abstract][Full Text] [Related]
39. Thermosensitive and biodegradable polymeric micelles for paclitaxel delivery. Soga O; van Nostrum CF; Fens M; Rijcken CJ; Schiffelers RM; Storm G; Hennink WE J Control Release; 2005 Mar; 103(2):341-53. PubMed ID: 15763618 [TBL] [Abstract][Full Text] [Related]
40. Novel cathepsin B-sensitive paclitaxel conjugate: Higher water solubility, better efficacy and lower toxicity. Liang L; Lin SW; Dai W; Lu JK; Yang TY; Xiang Y; Zhang Y; Li RT; Zhang Q J Control Release; 2012 Jun; 160(3):618-29. PubMed ID: 22410114 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]